US 8865217
Oral preparation comprising pioglitazone
granted A61KA61K31/4439A61K9/0056
Quick answer
US patent 8865217 (Oral preparation comprising pioglitazone) held by Takeda Pharmaceutical Company Limited expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4439, A61K9/0056, A61K9/0095, A61K9/2009